Before anything else, the question almost everyone brings to the start of treatment: how fast, and how much? The honest answer is that nobody can hand you your number in advance, and anyone who does is guessing. What can be described usefully is the shape of the journey: the way the arc tends to bend, where people are most often surprised, and why a straight line from first dose to goal was never a realistic expectation.
This article walks through that shape, phase by phase. You will notice something missing from it, which is numbers. There is a reason, and the reason deserves a section of its own before any phase talk begins.
Why we are not printing a number
Look at how GLP-1 results get reported and you will find a pile of apparently conflicting figures. One published trial reports one headline number; another reports something quite different. Trials also measure people over different lengths of time, so a short study and a long one are not comparing like with like. And even inside a single trial, the average depends on how you count: everyone who started, everyone who finished, everyone who stayed on the full dose, each method yields a different figure from the same data.
None of that means the research is wrong. It means group averages are descriptions, not forecasts. An average summarizes a crowd of very different people, most of whom landed nowhere near the average itself. No published figure tells you what your curve will look like, and we are not going to print one and let it imply otherwise. If you want your curve, the only honest source is your own log, kept well and read as a trend. What follows is deliberately qualitative: what many people describe, with wide individual variation, phase by phase.
The starting dose is an introduction
Every GLP-1 ladder opens with a low starting dose, and the starting dose is not a weight-loss dose. It is an introduction. The point of the first step is to let your body meet the medication gently while your prescriber watches how you tolerate it. Ozempic's lowest step, for example, is described in its prescribing information as a starting dose that is not intended for maintenance; other products follow the same philosophy with their own ladders.
Some people notice appetite changes during this opening stretch and some notice almost nothing, and both are ordinary. The early days have their own texture entirely: injection logistics or tablet routines, side effects that come and go, the strangeness of a new weekly rhythm. We gave that period its own article in Your First Week on a GLP-1: What to Expect and What to Track. The one expectation worth setting here is smaller: the opening stretch is the smallest chapter of the story, not the pattern for the rest of it.
The titration months, while the dose is still climbing
Treatment then enters its climbing phase. The dose moves up a fixed ladder, step by step, with the prescriber deciding each move at the intervals the schedule calls for. During these months the amount you are taking is still changing, which does strange things to expectations. A quiet stretch on one step can be followed by renewed change on the next. A body that tolerated one step comfortably can grumble briefly at the next one, because side effects, when they appear, commonly cluster around the days after an increase and tend to ease as the body settles in. That pattern has its own rhythm, which we described in The Week After a Dose Increase.
Underneath the changing schedule, something steadier is happening. The weekly medications build toward a stable level in the body over the first several weeks at any steady dose, which is one reason impressions formed early in treatment are a poor guide to how later months will feel. If you want the full picture of how the ladders work and why they climb at all, it is in GLP-1 Titration Schedules Explained, Medication by Medication. The practical takeaway for expectations is simpler: during the climb, your experience is attached to a dose that is temporary by design.
GLP 1 Tracker AppLog every dose on the real titration ladder, track weight and side effects alongside, and watch your own curve take shape. Free, private, no account.
Get the app
The stretch where change is usually most noticeable
Once the dose has climbed and settled for a while, many people describe a stretch where change accumulates noticeably. Clothes fit differently. Measurements move. Other people start commenting. Photos taken months apart show differences that daily mirrors missed. This is often the stretch people picture when they imagine GLP-1 treatment, and it is real, but it is a phase, not the whole story, and it does not arrive on a schedule.
Individual variation is enormous here, more than anywhere else on the timeline. Some people experience the noticeable stretch early, some later, some in bursts separated by quiet pauses, some so gradually that only the log reveals it. That is precisely why we refuse to attach numbers to phases. What many people describe is a period where the changes become visible to the world; what nobody can say is when yours will start or how long it will run. The instrument that tells you is your own record, kept consistently.
The slowing that surprises people
Sooner or later, the pace eases. This is the part of the arc that catches almost everyone off guard, because the mental model most of us carry is a straight line: steady effort, steady result, all the way to goal. Bodies do not work that way. As weight falls, there is less of you to carry around, and the body adapts along the way, so the same eating and activity gradually produce less change than they did when you started. The curve bends.
The bending is normal physiology, not a verdict. Yet it lands hard precisely because the earlier stretch set a faster expectation. People read a gentler slope as the medication failing, or as something they did wrong, when it is the shape virtually every sustained weight change eventually takes. Knowing the curve bends before it bends is the single most useful expectation this article can set: when the pace eases, you can meet it with curiosity about your data rather than alarm.
The flattening, and why meeting it calm matters
After the slowing, many people eventually reach a stretch where things sit roughly level for a while. This article deliberately stops at the edge of that territory, because what to do about a flat stretch is a separate subject with its own article: Hit a Plateau on a GLP-1? What Your Data Can Tell You. What belongs here is the before: knowing that flattening is a common, expected part of the arc changes how it feels when it arrives.
People who expected a straight line tend to meet a flat stretch with panic and self-experimentation. People who expected a curve meet it with their log, a look at what the trend is actually doing, and a conversation with their prescriber. Same physiology, very different experience. The plateau is a topic for that other article; the expectation is set here, in advance, which is the only time expectations can be set at all.
Your own log is the only curve that matters
Strip everything else away and the argument of this article is simple. Published averages describe groups and methods, not people. The arc has phases, and knowing their order protects you from misreading each one. And the only source that can tell you where you are on the arc is your own record: doses as actually taken, weight over time, side effects around changes, and a short note when life explains a reading. We laid out a minimal version of that routine in What to Log Every Day on a GLP-1: A Two-Minute Routine.
Reading that record well is a skill of its own, and it is the one we would hand you last: a noisy month of readings can hide a steady trend, and a flattering week can flatter. When you get to that point, our article on reading a weight trend line, linked below, takes over. The month by month picture above is everyone's in outline. The version with your numbers in it is the only one worth planning around.
Draw your own curveDoses, weight, notes and side effects in one private log that never leaves your phone. Free forever.
Download
Frequently asked questions
How much weight do people lose each month on a GLP-1?
We deliberately do not repeat a number. Published trials report different headline figures, run for different lengths of time, and produce different averages from the same data depending on how people are counted. An average describes a large group, not an individual, so no published figure forecasts your curve. If you want your number, the honest source is your own log, read as a trend over months rather than as any single month.
Does the starting dose of a GLP-1 cause weight loss?
The starting dose is an introduction, not a weight-loss dose. Its job is to let your body meet the medication gently while your prescriber watches how you tolerate it. Some people notice appetite changes on a starting dose and some notice very little, and both experiences are ordinary. Change, when it comes, usually develops as the dose climbs the prescribed ladder over the following months.
Why does GLP-1 weight loss slow down over time?
Slowing is part of the normal shape of treatment, not a sign of failure. As weight falls, the body carries less of itself around and adapts along the way, so the same effort gradually yields less change. Many people describe a stretch of noticeable change followed by a gentler slope, which surprises anyone expecting a straight line. When slowing becomes a genuinely flat stretch, that is a conversation for your prescriber, not a reason to adjust anything yourself.
Should I compare my GLP-1 results to the averages in the news?
No. Headline averages come from trials that differ in length, design and in how they count people, and even a single trial can yield several different averages from the same data depending on the method. More importantly, an average summarizes thousands of individual curves, most of which landed nowhere near the average itself. Comparing your real, individual curve to a group number is a reliable way to feel bad about progress that is actually normal.
What should I track to see my own GLP-1 results?
A simple, consistent log beats any published average: your doses as actually taken, weight readings kept long enough to show a trend, a short note when life explains a reading, and side effects with severity around dose changes. Measurements and how clothes fit add instruments beyond the scale. A couple of minutes a day, with a slightly longer look on shot day, is enough to draw the only curve that actually describes you.